Bamboo Therapeutics' Series A Round

Bamboo Therapeutics raised a round of funding on January 10, 2016. Investors include CureDuchenne Ventures.

Bamboo Therapeutics is an early-stage biotechnology company dedicated to developing gene therapies for orphan diseases. The gene therapy, initially called BMB-D001, has shown positive effects in Duche…

Articles about Bamboo Therapeutics' Series A Round: